Navigation Links
Escalon(R) Announces FDA 510(K) Clearance for D3 Hematology System
Date:12/18/2007

nterest in the D3 System abroad, we expect to accelerate the pace of our analyzer placements worldwide."

Drew Scientific is a diagnostics company specializing in the design, manufacture and distribution of instruments for blood cell counting and blood analysis. Drew Scientific is focused on providing instrumentation and consumables for the physician office and veterinary office laboratories. Drew Scientific also supplies the reagent and other consumable materials needed to operate the instruments.

Founded in 1987, Escalon develops markets and distributes ophthalmic diagnostic, surgical and pharmaceutical products as well as vascular access devices. Drew Scientific, which operates as a separate business unit, provides instrumentation and consumables for the diagnosis and monitoring of medical disorders in the areas of diabetes, cardiovascular diseases and hematology, as well as veterinary hematology and blood chemistry. Escalon seeks to utilize strategic partnerships to help finance its development programs and is also seeking acquisitions to further diversify its product line to achieve critical mass in sales and take better advantage of Escalon's distribution capabilities, although any such partnerships or acquisitions may not occur. Escalon has headquarters in Wayne, Pennsylvania and manufacturing operations in Long Island, New York, New Berlin, Wisconsin, Dallas, Texas, Waterbury, Connecticut and Barrow-in-Furness, U.K.

Note: This press release contains statements that are considered forward- looking under the Private Securities Litigation Reform Act of 1995, including statements about the Company's future prospects. They are based on the Company's current expectations and are subject to a number of uncertainties and risks, and actual results may differ materially. The uncertainties and risks include whether the Company is able to
-- implement its growth and marketing strategies, improve upon the

operations of the Company'
'/>"/>

SOURCE Escalon Medical Corp.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Escalon(R) Reports Financial Results for 2007 Fiscal Year
2. Escalon(R) Reports First Quarter Fiscal 2008 Results
3. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
4. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
5. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
6. HEI, Inc. Announces Sale of RFID Division Assets
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
8. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
9. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
10. Brooke Franchise Corporation Announces Selected July Results
11. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...AM,Ala.,Nov.24/PRNewswire-FirstCall/--HealthSouthC...ateintheBankofAmericaMerrillLynch2009CreditConfere...rVicePresidentandTreasurerEdFaywillbespeakingonThu...ewebcastliveandwillbeavailableat http://investor.h... AboutHealthSouth ,, HealthSouthisthenation,sl...
(Date:11/24/2009)...at pose choking hazard, are too loud, or contain d...(HealthDay News) -- As the holiday shopping season...toys are still being sold in stores across the Uni... annual Trouble in Toyland report, released Tues...RG). , The report focuses on toys that pose a c...
(Date:11/24/2009)...ibutes to the falls that plague older adults, stud...y News) -- Falls are a leading cause of death amon...chronic pain contributes to those accidents. , ... weakness, and is associated with mobility limitat...hors wrote. , "Chronic pain, no matter how we m...
(Date:11/24/2009)...n example, study finds no added use but higher cos... -- Direct-to-consumer drug ads may contribute to ...at examined sales of the widely used antiplatelet ...ta from 1999 to 2005 for 27 state Medicaid program...opidogrel did not increase people,s use of the dru...
(Date:11/24/2009)...Nov.24/PRNewswire-USNewswire/--Thereisanewgameinto...reduction,offeringpragmaticandrealisticstrategiesw...ed.SpearheadingthismovementisagroupcalledHAMS--Har...AMSisafree-of-charge,lay-ledsupportandinformationa...nstituteonAlcoholAbuseandAlcoholismtellsusthatonly...
Breaking Medicine News(10 mins):Health News:Dangerous Toys Still on Store Shelves, Report Finds 2Health News:Dangerous Toys Still on Store Shelves, Report Finds 3Health News:Chronic Pain Trips Up Seniors 2Health News:Chronic Pain Trips Up Seniors 3Health News:Advertising to Consumers May Raise Drug Prices 2Health News:Harm Reduction for Alcohol: An Idea Whose Time Has Arrived 2
...ernors and Mayors Support Event, ALEXANDRIA, Va.,...ealthcare Decisions Day (NHDD), will be the larges... professionals about,advance healthcare planning.,...are Decisions Day. "All Americans should use April...
...hm-Stecher, assistant professor in food science an... with tiny particles. His latest research project ...ver nanoparticles to improve the safety of the wor...such as microbe-resistant fabrics or non-biofoulin...
...il 10 Hooper Holmes,(Amex: HH ) today announced ... Chief Executive Officer and that Benjamin A. Curr...ctors. Mr. Bubbs, who has been a member of the,Boa...usly been named Chairman-Elect,continues as Chairm...
...fied opinion in Type II examination by independent...LLE, Colo., April 10 GHX has received an,unqualif...of its first Type,II SAS 70 compliance audit. The ...ed GHX,s exchange services, which,enable more than...
...y David Spiegel of Faculty of 1000 Medicine ( www....ween depression care management and survival rates...nt and well-conducted study of the effects of trea... sciences at Stanford University, Spiegel evaluate...
...ntries for the eighth,annual Michael E. DeBakey Jo...iomedical Research (FBR) and named after FBR,s cha...s open to all professional journalists whose repor...Dr. DeBakey,s many inventions and innovations have...
Other Medicine News:Health News:National Healthcare Decisions Day in All 50 States, DC, Puerto Rico, and Internationally 2Health News:Iowa State University researcher looks to use nanoparticles for food safety 2Health News:Hooper Holmes Names Roy Bubbs President and CEO, Benjamin Currier Continues as Chairman 2Health News:Hooper Holmes Names Roy Bubbs President and CEO, Benjamin Currier Continues as Chairman 3Health News:GHX Achieves SAS 70 Compliance 2Health News:DeBakey Awards to Recognize Excellence in Biomedical Research Journalism 2
(Date:11/24/2009)...rstCall/--NeurocrineBiosciences,Inc.(Nasdaq: NBIX ...ecutiveOfficerofNeurocrineBiosciences,willbepresen...einNewYork. ,, ThelivepresentationtakesplaceTue....m.PacificTime(PT).Thepresentationwillbesimultaneo... http://www.neurocrine.com . ,, Ifyouareunablet...
(Date:11/24/2009)...Newswire/--SatelliteHealthcare,oneofthenation,sfir...ajorsponsorofnephrologyresearch,todayannounceditsf...lahinhisefforttosupporttheSanJosehomelessthisThank...ulcareerasachefforthepast20years.ButNasrallah,slif...edwithEndStageRenalDisease(ESRD).Thediagnosisirrev...
(Date:11/24/2009)...rstCall/--Orexigen®Therapeutics,Inc.(Nasdaq: ...entofobesity,todayannouncedthatonNovember18,2009th...rsgrantedaninducementstockoptiontopurchase200,000s...pointedHeadoftheGlobalContraveProgram. ,, Thest...extentpermittedbylawandhasanexercisepricepersharee...
Breaking Medicine Technology:Satellite Healthcare and Renal Disease Survivor Elias Nasrallah Join Forces to Support the Homeless This Holiday Season 2Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 2Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 3Fate Therapeutics Closes 2430 Million Series B Financing 14844 1Fate Therapeutics Closes 2430 Million Series B Financing 14844 2Fate Therapeutics Closes 2430 Million Series B Financing 14844 3Fate Therapeutics Closes 2430 Million Series B Financing 14844 4Sleep Management Device Unit Sales to Grow at a Compound Annual Growth Rate of Over 16 25 as CMS Reimbursement Expands 6280 1Sleep Management Device Unit Sales to Grow at a Compound Annual Growth Rate of Over 16 25 as CMS Reimbursement Expands 6280 2Sleep Management Device Unit Sales to Grow at a Compound Annual Growth Rate of Over 16 25 as CMS Reimbursement Expands 6280 3China Medicine Announces Strong Third Quarter 2009 Results 6275 1China Medicine Announces Strong Third Quarter 2009 Results 6275 2China Medicine Announces Strong Third Quarter 2009 Results 6275 3China Medicine Announces Strong Third Quarter 2009 Results 6275 4China Medicine Announces Strong Third Quarter 2009 Results 6275 5China Medicine Announces Strong Third Quarter 2009 Results 6275 6China Medicine Announces Strong Third Quarter 2009 Results 6275 7China Medicine Announces Strong Third Quarter 2009 Results 6275 8China Medicine Announces Strong Third Quarter 2009 Results 6275 9China Medicine Announces Strong Third Quarter 2009 Results 6275 10China Medicine Announces Strong Third Quarter 2009 Results 6275 11China Medicine Announces Strong Third Quarter 2009 Results 6275 12China Medicine Announces Strong Third Quarter 2009 Results 6275 13China Medicine Announces Strong Third Quarter 2009 Results 6275 14China Medicine Announces Strong Third Quarter 2009 Results 6275 15
...., May 9 /PRNewswire-FirstCall/ -- Wyeth (NYSE: WY...inistration,s (FDA),San Juan District Office has i...ion of its Guayama, Puerto Rico manufacturing,faci... of the site.,The new classification means that an...ed by the Company or do not merit any further,regu...
...taminated with Diethylene Glycol,(DEG) Remains a P..., Md., May 4, 2007-The U.S. Food and Drug,Administ...rs,suppliers, drug repackers, and health professi...gilant in assuring that glycerin, a,sweetener comm...,prescription drug products, is not contaminated w...
Other Medicine Technology:FDA Re-Inspection Results in Positive Re-Classification of Guayama,Facility 2FDA Re-Inspection Results in Positive Re-Classification of Guayama,Facility 3FDA Advises Manufacturers to Test Glycerin for Possible,Contamination 2
511 Lightweight Pneumatic Conserver
...Conserver., ,Offers an average 5:1 increase in us...standard cannula. , ,The combination of the OXYMA...ulatory oxygen patients a superior alternative to ...warranty. , ,NOTE: Each model has passed the ...
WAVE 6203
...afts For Insertion Through A 1.0mm Incision., ,... Improved Ergonomics., ,Curved Shafts F...s For Improved Sub-Incisional Flap Purchase., ,...ring Sterilization., ,Reusable, Autoclaveable,...
Medicine Products: